Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

By Kruijf Esther  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 687-696

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

By Shayne Michelle   Crawford Jeffrey   Dale David   Culakova Eva   Lyman Gary  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer

By Hoesel Anneke  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 859-869

Springer Publishing Company

Access to resources Recommend Favorite

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

By Yardley Denise   Burris Howard   Peacock Nancy   Raefsky Eric   Melnik Marianne   Inhorn Roger   Shipley Dianna   Hainsworth John  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 471-475

Springer Publishing Company

Access to resources Recommend Favorite

Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer

By Tang Shou-Ching  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 206-214

Informa Healthcare

Access to resources Recommend Favorite